ES2180975T3 - Derivados de cicloalquilaminometilpirrolidina. - Google Patents

Derivados de cicloalquilaminometilpirrolidina.

Info

Publication number
ES2180975T3
ES2180975T3 ES97919690T ES97919690T ES2180975T3 ES 2180975 T3 ES2180975 T3 ES 2180975T3 ES 97919690 T ES97919690 T ES 97919690T ES 97919690 T ES97919690 T ES 97919690T ES 2180975 T3 ES2180975 T3 ES 2180975T3
Authority
ES
Spain
Prior art keywords
group
carbon atoms
alkyl
hydrogen atom
halogenomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919690T
Other languages
English (en)
Inventor
Makoto Takemura
Youichi Kimura
Katsuhiro Kawakami
Hitoshi Ohki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2180975T3 publication Critical patent/ES2180975T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicon Compounds (AREA)
  • Liquid Crystal (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)

Abstract

UN DERIVADO DE LA QUINOLONA REPRESENTADO POR LA FORMULA (I): EN LA QUE R 1 REPRESENTA UN GRUPO CICLOALQUILO; R SUP ,2 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO AMINO, UN GRUPO HIDROXILO, UN GRUPO TIOL, UN GRUPO HALOGENOMETILO, UN GRUPO ALQUILO, UN GRUPO ALQUENILO, UN GRUPO ALQUINILO O UN GRUPO ALCOXI. R 3 REPRESENTA UN GRUPO AMINO, UN GRUPO HALOGENOMETILO, UN GRUPO HALOGENOMETOXILO, UN GRUPO ALQUILO, UN GRUPO ALQUENILO, UN GRUPO ALQUINILO O UN GRUPO ALCOXI; R 4 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO DE 1 A 6 ATOMOS DE CARBONO; R 5 REPRESENTA UN GRUPO ALQUILO QUE TIENE DE 3 A 6 ATOMOS DE CARBONO; LOS ANTERIORES R 1 A R 5 PUEDEN SER SUSTITUIDOS; X REPRESENTA UN ATOMO DE HALOGENO O UN ATOMO DE HIDROGENO; E Y REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO FENILO, UN GRUPO ACETOXIMETILO, UN GRUPO PIVALOILOXIMETILO, UN GRUPO ETOXICARBONILO, UN GRUPO COLINA, UN GRUPO DIMETILAMINOETILO, UN GRUPO 5 - INDANILO, UN GRUPO FTALILDINILO, UN GRUPO 5 ALQUIL - 2 - OXO - 1,3 - DIOXOL - 4 - ILMETILO, UN GRUPO 3 - ACETOXI - 2 - OXOBUTILO, UN GRUPO ALQUILO CON 1 A 6 ATOMOS DE CARBONO, UN GRUPO ALCOXIMETIL QUE TIENE DE 2 A 7 ATOMOS DE CARBONO, O UN GRUPO FENILALQUILO CON 1 A 6 ATOMOS DE CARBONO EN SU MITAD ALQUILO, O UNA SAL DEL MISMO. EL COMPUESTO MUESTRA UNA AMPLIA Y POTENTE ACTIVIDAD ANTIMICROBIANA CONTRA DIVERSAS BACTERIAS, INCLUIDAS LAS RESISTENTES A LOS FARMACOS, ASI COMO UNA NOTABLE SEGURIDAD.
ES97919690T 1996-04-24 1997-04-24 Derivados de cicloalquilaminometilpirrolidina. Expired - Lifetime ES2180975T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10233496 1996-04-24

Publications (1)

Publication Number Publication Date
ES2180975T3 true ES2180975T3 (es) 2003-02-16

Family

ID=14324624

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919690T Expired - Lifetime ES2180975T3 (es) 1996-04-24 1997-04-24 Derivados de cicloalquilaminometilpirrolidina.

Country Status (17)

Country Link
US (1) US6194434B1 (es)
EP (1) EP0900793B1 (es)
JP (1) JP4127322B2 (es)
KR (1) KR100458146B1 (es)
CN (1) CN1116295C (es)
AT (1) ATE221063T1 (es)
AU (1) AU726378B2 (es)
BR (1) BR9708824A (es)
CA (1) CA2251927C (es)
DE (1) DE69714249T2 (es)
DK (1) DK0900793T3 (es)
EA (1) EA000878B1 (es)
ES (1) ES2180975T3 (es)
ID (1) ID16655A (es)
PT (1) PT900793E (es)
TW (1) TW425394B (es)
WO (1) WO1997040037A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3192700A (en) 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
ATE443064T1 (de) 2002-03-18 2009-10-15 Kyorin Seiyaku Kk 10-(3-cyclo propyl amino methyl-1-pyrrolidinyl) pyridobenzoxazin carbonsäure derivat mit wirkung gegen resistente bakterien
SI1666477T1 (sl) * 2003-09-10 2013-10-30 Kyorin Pharmaceutical Co., Ltd. Derivati 7-(4-substituiran 3-ciklopropilaminometil-1-pirolidinil) kinolonkarboksilne kisline
GB0428250D0 (en) * 2004-12-23 2005-01-26 Novartis Ag Organic compounds
US8222407B2 (en) * 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
SG10201908007UA (en) 2015-03-13 2019-10-30 Kyorin Pharmaceutical Co Ltd Respiratory infection treating agent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
JPH0696572B2 (ja) 1985-07-17 1994-11-30 大日本製薬株式会社 ピリドンカルボン酸誘導体、そのエステルおよびその塩
US4771055A (en) 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
US4965273A (en) * 1986-10-08 1990-10-23 Bristol-Myers Company Certain 1-tertiary-butyl-naphthyridone carboxylic acid derivatives anti-bacterial agents
ZA877471B (en) * 1986-10-08 1988-04-05 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
US4954507A (en) * 1986-10-08 1990-09-04 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
DE3814517A1 (de) 1988-02-05 1989-08-17 Bayer Ag Chinolon- und naphthyridoncarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.

Also Published As

Publication number Publication date
DE69714249D1 (en) 2002-08-29
AU726378B2 (en) 2000-11-02
CA2251927A1 (en) 1997-10-30
ID16655A (id) 1997-10-30
HK1018786A1 (en) 2000-01-07
KR20000010578A (ko) 2000-02-15
CN1116295C (zh) 2003-07-30
PT900793E (pt) 2002-11-29
CA2251927C (en) 2005-02-15
ATE221063T1 (de) 2002-08-15
US6194434B1 (en) 2001-02-27
CN1222151A (zh) 1999-07-07
JP4127322B2 (ja) 2008-07-30
TW425394B (en) 2001-03-11
EP0900793B1 (en) 2002-07-24
DE69714249T2 (de) 2003-03-27
EA000878B1 (ru) 2000-06-26
EP0900793A4 (en) 1999-07-07
BR9708824A (pt) 1999-08-03
KR100458146B1 (ko) 2005-06-13
DK0900793T3 (da) 2002-10-14
EA199800952A1 (ru) 1999-04-29
WO1997040037A1 (en) 1997-10-30
AU2407297A (en) 1997-11-12
EP0900793A1 (en) 1999-03-10

Similar Documents

Publication Publication Date Title
DK0976748T3 (da) Pyrrolidinderivater med phospholispase A2-hæmmende aktivitet
NZ248099A (en) Use of spiro-oxathiolane quinuclidine derivatives for treating sjoegren syndrome
PT919553E (pt) Derivados de aminociclopropano cis-substituidos
ATE223411T1 (de) 1-methylcarbapenem-derivate
DK0947513T3 (da) Tricykliske aminderivater
ES2180975T3 (es) Derivados de cicloalquilaminometilpirrolidina.
EP0995744A4 (en) CIS-SUBSTITUTED DERIVATIVES OF FLUOROMETHYLPYRROLIDINE
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
MY136916A (en) Antibacterial dehaloganated quinolone compounds
DK0924213T3 (da) Pyrodobenzoxazinderivater
ES2072644T3 (es) Composicion anticataratas.
TH43868A (th) อนุพันธ์ของไซโคลอัลคิลอะมิโนเมทิลเพอโรลิดีน
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit